# Infinovo Medical Co

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/infinovo-medical-co

- Industry: Medical Devices & Equipment
- Headquarters: Nantong, China
- Website: www.infinovo.com
- Latest round: Series C (Jun 16, 2021)
- Investors on record: 11

## About

Based in Nantong, China, and established in 2016, Infinovo Medical Co Ltd is a medical equipment company that provides Continuous Glucose Monitoring (CGM) and data monitoring applications. It has acquired more than 13 quality systems and product certifications such as CFDA, ISO13485, CE, etc. The technology R&D center has been set up in Suzhou. The management has been involved in the diabetes field for more than 10 years on average and has worked at Bayer, BD, Medtronic, and other companies. In June 2021, it closed a series C funding. In March 2022, Glunovo®GN-I was launched. 

The company is committed to continuous glucose monitoring (CGM) system technology and diabetes management. The products include Glunovo i3 and Glunovo p3, which contain functions of real-time monitoring, smart report, and so on. Its products have been sold to more than 30 overseas countries and regions.

The company generates revenue by selling continuous glucose monitoring products.

In the future, Infinovo will focus on research in semi-permeable membrane materials, electronic media technology, and other fields.

## Funding rounds

- Series C, Jun 16, 2021 — YF Capital, Loyal Valley Capital, TF Capital, Qianhai Ark Capital, Ming Bioventures, Life Venture, HM Capital, Zhiyang Capital
- Series B, Jul 28, 2020 — Vertex Ventures China
- Series A, Jan 31, 2019 — Loyal Valley Capital, Prosperico Ventures, Rays Venture Capital

## Investors

- Loyal Valley Capital (https://capitalatlas.ai/funds/loyal-valley-capital) — Series A, Series C
- Prosperico Ventures (https://capitalatlas.ai/funds/prosperico-ventures) — Series A
- Rays Venture Capital (https://capitalatlas.ai/funds/rays-venture-capital) — Series A
- Vertex Ventures China (https://capitalatlas.ai/funds/vertex-ventures-china) — Series B
- YF Capital (https://capitalatlas.ai/funds/yf-capital) — Series C
- TF Capital — Series C
- Qianhai Ark Capital (https://capitalatlas.ai/funds/qianhai-ark-capital) — Series C
- Ming Bioventures (https://capitalatlas.ai/funds/ming-bioventures) — Series C
- Life Venture — Series C
- HM Capital (https://capitalatlas.ai/funds/hm-capital) — Series C
- Zhiyang Capital — Series C